Research Progress in Chinese Medicine Preparations for Promoting Blood Circulation and Removing Blood Stasis for Cirrhotic Patients with Portal Vein Thrombosis Following Splenectomy
- 1 September 2022
- journal article
- review article
- Published by Springer Science and Business Media LLC in Chinese Journal of Integrated Medicine
- Vol. 28 (9), 855-863
- https://doi.org/10.1007/s11655-020-3271-8
Abstract
This article presented an overview of the therapeutic effects of Chinese medicine (CM) preparations for promoting blood circulation and removing blood stasis for patients with portal vein thrombosis (PVT) after splenectomy. Based on published clinical researches of CM preparations for PVT after splenectomy in patients with cirrhotic portal hypertension (CPH), this paper evaluated the incidence of PVT, and explored potential active components and mechanisms of CM preparations. Safflower Yellow Injection, Danshen Injection (& x4e39;(sic)(sic)& x5c04;& x6db2;) Danhong Injection (& x4e39;& x7ea2;(sic)& x5c04;& x6db2;), and Compound Danshen Dropping Pill ((sic)(sic)& x4e39;(sic)& x6ef4;& x4e38;) achieved good curative effect alone or combined with anticoagulant therapy. In addition, Compound Biejia Ruangan Tablet ((sic)(sic)& x9cd6;& x7532;& x8f6f;& x809d;(sic)) and Anluo Huaxian Pill ((sic)(sic)(sic)& x7ea4;& x4e38;) can also significantly improve the hemodynamic disorders of portal vein system in patients with cirrhosis. Considering the role of CM preparations in ameliorating the incidence of PVT after splenectomy in patients with CPH, we suggested that future research should provide more attention to CM alone or CM combined with anticoagulant for cirrhosis with PVT.This publication has 47 references indexed in Scilit:
- Paeoniflorin Protects against Ischemia-Induced Brain Damages in Rats via Inhibiting MAPKs/NF-κB-Mediated Inflammatory ResponsesPLOS ONE, 2012
- The Coagulopathy of Chronic Liver DiseaseThe New England Journal of Medicine, 2011
- The potential role of new oral anticoagulants in the prevention and treatment of thromboembolismPharmacology & Therapeutics, 2011
- Antiplatelet combinations for prevention of atherothrombotic eventsVascular Health and Risk Management, 2011
- Risk factors for portal venous thrombosis after splenectomy in patients with cirrhosis and portal hypertension (Br J Surg 2010; 97: 910–916)British Journal of Surgery, 2010
- Safety and Efficacy of Anticoagulation Therapy With Low Molecular Weight Heparin for Portal Vein Thrombosis in Patients With Liver CirrhosisJournal of Clinical Gastroenterology, 2010
- Risk factors for portal venous thrombosis after splenectomy in patients with cirrhosis and portal hypertensionBritish Journal of Surgery, 2010
- Diameter of splenic vein is a risk factor for portal or splenic vein thrombosis after laparoscopic splenectomySurgery, 2009
- Differential gene expression profiles in coronary heart disease patients of blood stasis syndrome in traditional Chinese medicine and clinical role of target geneChinese Journal of Integrated Medicine, 2009
- Vascular disorders of the liverHepatology, 2008